Global Biopharmaceutical Excipients Market Growth 2025-2031
The global Biopharmaceutical Excipients market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Biopharmaceutical Excipients Industry Forecast” looks at past sales and reviews total world Biopharmaceutical Excipients sales in 2024, providing a comprehensive analysis by region and market sector of projected Biopharmaceutical Excipients sales for 2025 through 2031. With Biopharmaceutical Excipients sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biopharmaceutical Excipients industry.
This Insight Report provides a comprehensive analysis of the global Biopharmaceutical Excipients landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biopharmaceutical Excipients portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biopharmaceutical Excipients market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biopharmaceutical Excipients and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biopharmaceutical Excipients.
This report presents a comprehensive overview, market shares, and growth opportunities of Biopharmaceutical Excipients market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Biopharmaceutical Excipients market?
What factors are driving Biopharmaceutical Excipients market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Biopharmaceutical Excipients market opportunities vary by end market size?
How does Biopharmaceutical Excipients break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Biopharmaceutical Excipients Industry Forecast” looks at past sales and reviews total world Biopharmaceutical Excipients sales in 2024, providing a comprehensive analysis by region and market sector of projected Biopharmaceutical Excipients sales for 2025 through 2031. With Biopharmaceutical Excipients sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biopharmaceutical Excipients industry.
This Insight Report provides a comprehensive analysis of the global Biopharmaceutical Excipients landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biopharmaceutical Excipients portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biopharmaceutical Excipients market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biopharmaceutical Excipients and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biopharmaceutical Excipients.
This report presents a comprehensive overview, market shares, and growth opportunities of Biopharmaceutical Excipients market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Solubilizers& Surfactants/Emulsifiers
- Polyols
- Carbohydrates
- Other
- Biopharmaceutical Downstream
- Biopharmaceutical Upstream
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- BASF SE
- ABITEC Corp
- Colorcon, Inc
- DFE Pharma
- Meggle AG
- Pharmonix Biological
- Roquette
- Sigachi Industries
- Signet Chemical Corporation
- Spectrum Chemical Manufacturing Corp
- SPI Pharma
What is the 10-year outlook for the global Biopharmaceutical Excipients market?
What factors are driving Biopharmaceutical Excipients market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Biopharmaceutical Excipients market opportunities vary by end market size?
How does Biopharmaceutical Excipients break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biopharmaceutical Excipients Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Biopharmaceutical Excipients by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Biopharmaceutical Excipients by Country/Region, 2020, 2024 & 2031
2.2 Biopharmaceutical Excipients Segment by Type
2.2.1 Solubilizers& Surfactants/Emulsifiers
2.2.2 Polyols
2.2.3 Carbohydrates
2.2.4 Other
2.3 Biopharmaceutical Excipients Sales by Type
2.3.1 Global Biopharmaceutical Excipients Sales Market Share by Type (2020-2025)
2.3.2 Global Biopharmaceutical Excipients Revenue and Market Share by Type (2020-2025)
2.3.3 Global Biopharmaceutical Excipients Sale Price by Type (2020-2025)
2.4 Biopharmaceutical Excipients Segment by Application
2.4.1 Biopharmaceutical Downstream
2.4.2 Biopharmaceutical Upstream
2.5 Biopharmaceutical Excipients Sales by Application
2.5.1 Global Biopharmaceutical Excipients Sale Market Share by Application (2020-2025)
2.5.2 Global Biopharmaceutical Excipients Revenue and Market Share by Application (2020-2025)
2.5.3 Global Biopharmaceutical Excipients Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Biopharmaceutical Excipients Breakdown Data by Company
3.1.1 Global Biopharmaceutical Excipients Annual Sales by Company (2020-2025)
3.1.2 Global Biopharmaceutical Excipients Sales Market Share by Company (2020-2025)
3.2 Global Biopharmaceutical Excipients Annual Revenue by Company (2020-2025)
3.2.1 Global Biopharmaceutical Excipients Revenue by Company (2020-2025)
3.2.2 Global Biopharmaceutical Excipients Revenue Market Share by Company (2020-2025)
3.3 Global Biopharmaceutical Excipients Sale Price by Company
3.4 Key Manufacturers Biopharmaceutical Excipients Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Biopharmaceutical Excipients Product Location Distribution
3.4.2 Players Biopharmaceutical Excipients Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BIOPHARMACEUTICAL EXCIPIENTS BY GEOGRAPHIC REGION
4.1 World Historic Biopharmaceutical Excipients Market Size by Geographic Region (2020-2025)
4.1.1 Global Biopharmaceutical Excipients Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Biopharmaceutical Excipients Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Biopharmaceutical Excipients Market Size by Country/Region (2020-2025)
4.2.1 Global Biopharmaceutical Excipients Annual Sales by Country/Region (2020-2025)
4.2.2 Global Biopharmaceutical Excipients Annual Revenue by Country/Region (2020-2025)
4.3 Americas Biopharmaceutical Excipients Sales Growth
4.4 APAC Biopharmaceutical Excipients Sales Growth
4.5 Europe Biopharmaceutical Excipients Sales Growth
4.6 Middle East & Africa Biopharmaceutical Excipients Sales Growth
5 AMERICAS
5.1 Americas Biopharmaceutical Excipients Sales by Country
5.1.1 Americas Biopharmaceutical Excipients Sales by Country (2020-2025)
5.1.2 Americas Biopharmaceutical Excipients Revenue by Country (2020-2025)
5.2 Americas Biopharmaceutical Excipients Sales by Type (2020-2025)
5.3 Americas Biopharmaceutical Excipients Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biopharmaceutical Excipients Sales by Region
6.1.1 APAC Biopharmaceutical Excipients Sales by Region (2020-2025)
6.1.2 APAC Biopharmaceutical Excipients Revenue by Region (2020-2025)
6.2 APAC Biopharmaceutical Excipients Sales by Type (2020-2025)
6.3 APAC Biopharmaceutical Excipients Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Biopharmaceutical Excipients by Country
7.1.1 Europe Biopharmaceutical Excipients Sales by Country (2020-2025)
7.1.2 Europe Biopharmaceutical Excipients Revenue by Country (2020-2025)
7.2 Europe Biopharmaceutical Excipients Sales by Type (2020-2025)
7.3 Europe Biopharmaceutical Excipients Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biopharmaceutical Excipients by Country
8.1.1 Middle East & Africa Biopharmaceutical Excipients Sales by Country (2020-2025)
8.1.2 Middle East & Africa Biopharmaceutical Excipients Revenue by Country (2020-2025)
8.2 Middle East & Africa Biopharmaceutical Excipients Sales by Type (2020-2025)
8.3 Middle East & Africa Biopharmaceutical Excipients Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Biopharmaceutical Excipients
10.3 Manufacturing Process Analysis of Biopharmaceutical Excipients
10.4 Industry Chain Structure of Biopharmaceutical Excipients
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Biopharmaceutical Excipients Distributors
11.3 Biopharmaceutical Excipients Customer
12 WORLD FORECAST REVIEW FOR BIOPHARMACEUTICAL EXCIPIENTS BY GEOGRAPHIC REGION
12.1 Global Biopharmaceutical Excipients Market Size Forecast by Region
12.1.1 Global Biopharmaceutical Excipients Forecast by Region (2026-2031)
12.1.2 Global Biopharmaceutical Excipients Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Biopharmaceutical Excipients Forecast by Type (2026-2031)
12.7 Global Biopharmaceutical Excipients Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 BASF SE
13.1.1 BASF SE Company Information
13.1.2 BASF SE Biopharmaceutical Excipients Product Portfolios and Specifications
13.1.3 BASF SE Biopharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 BASF SE Main Business Overview
13.1.5 BASF SE Latest Developments
13.2 ABITEC Corp
13.2.1 ABITEC Corp Company Information
13.2.2 ABITEC Corp Biopharmaceutical Excipients Product Portfolios and Specifications
13.2.3 ABITEC Corp Biopharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 ABITEC Corp Main Business Overview
13.2.5 ABITEC Corp Latest Developments
13.3 Colorcon, Inc
13.3.1 Colorcon, Inc Company Information
13.3.2 Colorcon, Inc Biopharmaceutical Excipients Product Portfolios and Specifications
13.3.3 Colorcon, Inc Biopharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Colorcon, Inc Main Business Overview
13.3.5 Colorcon, Inc Latest Developments
13.4 DFE Pharma
13.4.1 DFE Pharma Company Information
13.4.2 DFE Pharma Biopharmaceutical Excipients Product Portfolios and Specifications
13.4.3 DFE Pharma Biopharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 DFE Pharma Main Business Overview
13.4.5 DFE Pharma Latest Developments
13.5 Meggle AG
13.5.1 Meggle AG Company Information
13.5.2 Meggle AG Biopharmaceutical Excipients Product Portfolios and Specifications
13.5.3 Meggle AG Biopharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Meggle AG Main Business Overview
13.5.5 Meggle AG Latest Developments
13.6 Pharmonix Biological
13.6.1 Pharmonix Biological Company Information
13.6.2 Pharmonix Biological Biopharmaceutical Excipients Product Portfolios and Specifications
13.6.3 Pharmonix Biological Biopharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Pharmonix Biological Main Business Overview
13.6.5 Pharmonix Biological Latest Developments
13.7 Roquette
13.7.1 Roquette Company Information
13.7.2 Roquette Biopharmaceutical Excipients Product Portfolios and Specifications
13.7.3 Roquette Biopharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Roquette Main Business Overview
13.7.5 Roquette Latest Developments
13.8 Sigachi Industries
13.8.1 Sigachi Industries Company Information
13.8.2 Sigachi Industries Biopharmaceutical Excipients Product Portfolios and Specifications
13.8.3 Sigachi Industries Biopharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Sigachi Industries Main Business Overview
13.8.5 Sigachi Industries Latest Developments
13.9 Signet Chemical Corporation
13.9.1 Signet Chemical Corporation Company Information
13.9.2 Signet Chemical Corporation Biopharmaceutical Excipients Product Portfolios and Specifications
13.9.3 Signet Chemical Corporation Biopharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Signet Chemical Corporation Main Business Overview
13.9.5 Signet Chemical Corporation Latest Developments
13.10 Spectrum Chemical Manufacturing Corp
13.10.1 Spectrum Chemical Manufacturing Corp Company Information
13.10.2 Spectrum Chemical Manufacturing Corp Biopharmaceutical Excipients Product Portfolios and Specifications
13.10.3 Spectrum Chemical Manufacturing Corp Biopharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Spectrum Chemical Manufacturing Corp Main Business Overview
13.10.5 Spectrum Chemical Manufacturing Corp Latest Developments
13.11 SPI Pharma
13.11.1 SPI Pharma Company Information
13.11.2 SPI Pharma Biopharmaceutical Excipients Product Portfolios and Specifications
13.11.3 SPI Pharma Biopharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 SPI Pharma Main Business Overview
13.11.5 SPI Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biopharmaceutical Excipients Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Biopharmaceutical Excipients by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Biopharmaceutical Excipients by Country/Region, 2020, 2024 & 2031
2.2 Biopharmaceutical Excipients Segment by Type
2.2.1 Solubilizers& Surfactants/Emulsifiers
2.2.2 Polyols
2.2.3 Carbohydrates
2.2.4 Other
2.3 Biopharmaceutical Excipients Sales by Type
2.3.1 Global Biopharmaceutical Excipients Sales Market Share by Type (2020-2025)
2.3.2 Global Biopharmaceutical Excipients Revenue and Market Share by Type (2020-2025)
2.3.3 Global Biopharmaceutical Excipients Sale Price by Type (2020-2025)
2.4 Biopharmaceutical Excipients Segment by Application
2.4.1 Biopharmaceutical Downstream
2.4.2 Biopharmaceutical Upstream
2.5 Biopharmaceutical Excipients Sales by Application
2.5.1 Global Biopharmaceutical Excipients Sale Market Share by Application (2020-2025)
2.5.2 Global Biopharmaceutical Excipients Revenue and Market Share by Application (2020-2025)
2.5.3 Global Biopharmaceutical Excipients Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Biopharmaceutical Excipients Breakdown Data by Company
3.1.1 Global Biopharmaceutical Excipients Annual Sales by Company (2020-2025)
3.1.2 Global Biopharmaceutical Excipients Sales Market Share by Company (2020-2025)
3.2 Global Biopharmaceutical Excipients Annual Revenue by Company (2020-2025)
3.2.1 Global Biopharmaceutical Excipients Revenue by Company (2020-2025)
3.2.2 Global Biopharmaceutical Excipients Revenue Market Share by Company (2020-2025)
3.3 Global Biopharmaceutical Excipients Sale Price by Company
3.4 Key Manufacturers Biopharmaceutical Excipients Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Biopharmaceutical Excipients Product Location Distribution
3.4.2 Players Biopharmaceutical Excipients Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BIOPHARMACEUTICAL EXCIPIENTS BY GEOGRAPHIC REGION
4.1 World Historic Biopharmaceutical Excipients Market Size by Geographic Region (2020-2025)
4.1.1 Global Biopharmaceutical Excipients Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Biopharmaceutical Excipients Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Biopharmaceutical Excipients Market Size by Country/Region (2020-2025)
4.2.1 Global Biopharmaceutical Excipients Annual Sales by Country/Region (2020-2025)
4.2.2 Global Biopharmaceutical Excipients Annual Revenue by Country/Region (2020-2025)
4.3 Americas Biopharmaceutical Excipients Sales Growth
4.4 APAC Biopharmaceutical Excipients Sales Growth
4.5 Europe Biopharmaceutical Excipients Sales Growth
4.6 Middle East & Africa Biopharmaceutical Excipients Sales Growth
5 AMERICAS
5.1 Americas Biopharmaceutical Excipients Sales by Country
5.1.1 Americas Biopharmaceutical Excipients Sales by Country (2020-2025)
5.1.2 Americas Biopharmaceutical Excipients Revenue by Country (2020-2025)
5.2 Americas Biopharmaceutical Excipients Sales by Type (2020-2025)
5.3 Americas Biopharmaceutical Excipients Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biopharmaceutical Excipients Sales by Region
6.1.1 APAC Biopharmaceutical Excipients Sales by Region (2020-2025)
6.1.2 APAC Biopharmaceutical Excipients Revenue by Region (2020-2025)
6.2 APAC Biopharmaceutical Excipients Sales by Type (2020-2025)
6.3 APAC Biopharmaceutical Excipients Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Biopharmaceutical Excipients by Country
7.1.1 Europe Biopharmaceutical Excipients Sales by Country (2020-2025)
7.1.2 Europe Biopharmaceutical Excipients Revenue by Country (2020-2025)
7.2 Europe Biopharmaceutical Excipients Sales by Type (2020-2025)
7.3 Europe Biopharmaceutical Excipients Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biopharmaceutical Excipients by Country
8.1.1 Middle East & Africa Biopharmaceutical Excipients Sales by Country (2020-2025)
8.1.2 Middle East & Africa Biopharmaceutical Excipients Revenue by Country (2020-2025)
8.2 Middle East & Africa Biopharmaceutical Excipients Sales by Type (2020-2025)
8.3 Middle East & Africa Biopharmaceutical Excipients Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Biopharmaceutical Excipients
10.3 Manufacturing Process Analysis of Biopharmaceutical Excipients
10.4 Industry Chain Structure of Biopharmaceutical Excipients
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Biopharmaceutical Excipients Distributors
11.3 Biopharmaceutical Excipients Customer
12 WORLD FORECAST REVIEW FOR BIOPHARMACEUTICAL EXCIPIENTS BY GEOGRAPHIC REGION
12.1 Global Biopharmaceutical Excipients Market Size Forecast by Region
12.1.1 Global Biopharmaceutical Excipients Forecast by Region (2026-2031)
12.1.2 Global Biopharmaceutical Excipients Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Biopharmaceutical Excipients Forecast by Type (2026-2031)
12.7 Global Biopharmaceutical Excipients Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 BASF SE
13.1.1 BASF SE Company Information
13.1.2 BASF SE Biopharmaceutical Excipients Product Portfolios and Specifications
13.1.3 BASF SE Biopharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 BASF SE Main Business Overview
13.1.5 BASF SE Latest Developments
13.2 ABITEC Corp
13.2.1 ABITEC Corp Company Information
13.2.2 ABITEC Corp Biopharmaceutical Excipients Product Portfolios and Specifications
13.2.3 ABITEC Corp Biopharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 ABITEC Corp Main Business Overview
13.2.5 ABITEC Corp Latest Developments
13.3 Colorcon, Inc
13.3.1 Colorcon, Inc Company Information
13.3.2 Colorcon, Inc Biopharmaceutical Excipients Product Portfolios and Specifications
13.3.3 Colorcon, Inc Biopharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Colorcon, Inc Main Business Overview
13.3.5 Colorcon, Inc Latest Developments
13.4 DFE Pharma
13.4.1 DFE Pharma Company Information
13.4.2 DFE Pharma Biopharmaceutical Excipients Product Portfolios and Specifications
13.4.3 DFE Pharma Biopharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 DFE Pharma Main Business Overview
13.4.5 DFE Pharma Latest Developments
13.5 Meggle AG
13.5.1 Meggle AG Company Information
13.5.2 Meggle AG Biopharmaceutical Excipients Product Portfolios and Specifications
13.5.3 Meggle AG Biopharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Meggle AG Main Business Overview
13.5.5 Meggle AG Latest Developments
13.6 Pharmonix Biological
13.6.1 Pharmonix Biological Company Information
13.6.2 Pharmonix Biological Biopharmaceutical Excipients Product Portfolios and Specifications
13.6.3 Pharmonix Biological Biopharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Pharmonix Biological Main Business Overview
13.6.5 Pharmonix Biological Latest Developments
13.7 Roquette
13.7.1 Roquette Company Information
13.7.2 Roquette Biopharmaceutical Excipients Product Portfolios and Specifications
13.7.3 Roquette Biopharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Roquette Main Business Overview
13.7.5 Roquette Latest Developments
13.8 Sigachi Industries
13.8.1 Sigachi Industries Company Information
13.8.2 Sigachi Industries Biopharmaceutical Excipients Product Portfolios and Specifications
13.8.3 Sigachi Industries Biopharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Sigachi Industries Main Business Overview
13.8.5 Sigachi Industries Latest Developments
13.9 Signet Chemical Corporation
13.9.1 Signet Chemical Corporation Company Information
13.9.2 Signet Chemical Corporation Biopharmaceutical Excipients Product Portfolios and Specifications
13.9.3 Signet Chemical Corporation Biopharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Signet Chemical Corporation Main Business Overview
13.9.5 Signet Chemical Corporation Latest Developments
13.10 Spectrum Chemical Manufacturing Corp
13.10.1 Spectrum Chemical Manufacturing Corp Company Information
13.10.2 Spectrum Chemical Manufacturing Corp Biopharmaceutical Excipients Product Portfolios and Specifications
13.10.3 Spectrum Chemical Manufacturing Corp Biopharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Spectrum Chemical Manufacturing Corp Main Business Overview
13.10.5 Spectrum Chemical Manufacturing Corp Latest Developments
13.11 SPI Pharma
13.11.1 SPI Pharma Company Information
13.11.2 SPI Pharma Biopharmaceutical Excipients Product Portfolios and Specifications
13.11.3 SPI Pharma Biopharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 SPI Pharma Main Business Overview
13.11.5 SPI Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Biopharmaceutical Excipients Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Biopharmaceutical Excipients Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Solubilizers& Surfactants/Emulsifiers
Table 4. Major Players of Polyols
Table 5. Major Players of Carbohydrates
Table 6. Major Players of Other
Table 7. Global Biopharmaceutical Excipients Sales by Type (2020-2025) & (K MT)
Table 8. Global Biopharmaceutical Excipients Sales Market Share by Type (2020-2025)
Table 9. Global Biopharmaceutical Excipients Revenue by Type (2020-2025) & ($ million)
Table 10. Global Biopharmaceutical Excipients Revenue Market Share by Type (2020-2025)
Table 11. Global Biopharmaceutical Excipients Sale Price by Type (2020-2025) & (USD/MT)
Table 12. Global Biopharmaceutical Excipients Sale by Application (2020-2025) & (K MT)
Table 13. Global Biopharmaceutical Excipients Sale Market Share by Application (2020-2025)
Table 14. Global Biopharmaceutical Excipients Revenue by Application (2020-2025) & ($ million)
Table 15. Global Biopharmaceutical Excipients Revenue Market Share by Application (2020-2025)
Table 16. Global Biopharmaceutical Excipients Sale Price by Application (2020-2025) & (USD/MT)
Table 17. Global Biopharmaceutical Excipients Sales by Company (2020-2025) & (K MT)
Table 18. Global Biopharmaceutical Excipients Sales Market Share by Company (2020-2025)
Table 19. Global Biopharmaceutical Excipients Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Biopharmaceutical Excipients Revenue Market Share by Company (2020-2025)
Table 21. Global Biopharmaceutical Excipients Sale Price by Company (2020-2025) & (USD/MT)
Table 22. Key Manufacturers Biopharmaceutical Excipients Producing Area Distribution and Sales Area
Table 23. Players Biopharmaceutical Excipients Products Offered
Table 24. Biopharmaceutical Excipients Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Biopharmaceutical Excipients Sales by Geographic Region (2020-2025) & (K MT)
Table 28. Global Biopharmaceutical Excipients Sales Market Share Geographic Region (2020-2025)
Table 29. Global Biopharmaceutical Excipients Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Biopharmaceutical Excipients Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Biopharmaceutical Excipients Sales by Country/Region (2020-2025) & (K MT)
Table 32. Global Biopharmaceutical Excipients Sales Market Share by Country/Region (2020-2025)
Table 33. Global Biopharmaceutical Excipients Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Biopharmaceutical Excipients Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Biopharmaceutical Excipients Sales by Country (2020-2025) & (K MT)
Table 36. Americas Biopharmaceutical Excipients Sales Market Share by Country (2020-2025)
Table 37. Americas Biopharmaceutical Excipients Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Biopharmaceutical Excipients Sales by Type (2020-2025) & (K MT)
Table 39. Americas Biopharmaceutical Excipients Sales by Application (2020-2025) & (K MT)
Table 40. APAC Biopharmaceutical Excipients Sales by Region (2020-2025) & (K MT)
Table 41. APAC Biopharmaceutical Excipients Sales Market Share by Region (2020-2025)
Table 42. APAC Biopharmaceutical Excipients Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Biopharmaceutical Excipients Sales by Type (2020-2025) & (K MT)
Table 44. APAC Biopharmaceutical Excipients Sales by Application (2020-2025) & (K MT)
Table 45. Europe Biopharmaceutical Excipients Sales by Country (2020-2025) & (K MT)
Table 46. Europe Biopharmaceutical Excipients Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Biopharmaceutical Excipients Sales by Type (2020-2025) & (K MT)
Table 48. Europe Biopharmaceutical Excipients Sales by Application (2020-2025) & (K MT)
Table 49. Middle East & Africa Biopharmaceutical Excipients Sales by Country (2020-2025) & (K MT)
Table 50. Middle East & Africa Biopharmaceutical Excipients Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Biopharmaceutical Excipients Sales by Type (2020-2025) & (K MT)
Table 52. Middle East & Africa Biopharmaceutical Excipients Sales by Application (2020-2025) & (K MT)
Table 53. Key Market Drivers & Growth Opportunities of Biopharmaceutical Excipients
Table 54. Key Market Challenges & Risks of Biopharmaceutical Excipients
Table 55. Key Industry Trends of Biopharmaceutical Excipients
Table 56. Biopharmaceutical Excipients Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Biopharmaceutical Excipients Distributors List
Table 59. Biopharmaceutical Excipients Customer List
Table 60. Global Biopharmaceutical Excipients Sales Forecast by Region (2026-2031) & (K MT)
Table 61. Global Biopharmaceutical Excipients Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Biopharmaceutical Excipients Sales Forecast by Country (2026-2031) & (K MT)
Table 63. Americas Biopharmaceutical Excipients Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Biopharmaceutical Excipients Sales Forecast by Region (2026-2031) & (K MT)
Table 65. APAC Biopharmaceutical Excipients Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Biopharmaceutical Excipients Sales Forecast by Country (2026-2031) & (K MT)
Table 67. Europe Biopharmaceutical Excipients Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Biopharmaceutical Excipients Sales Forecast by Country (2026-2031) & (K MT)
Table 69. Middle East & Africa Biopharmaceutical Excipients Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Biopharmaceutical Excipients Sales Forecast by Type (2026-2031) & (K MT)
Table 71. Global Biopharmaceutical Excipients Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Biopharmaceutical Excipients Sales Forecast by Application (2026-2031) & (K MT)
Table 73. Global Biopharmaceutical Excipients Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. BASF SE Basic Information, Biopharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 75. BASF SE Biopharmaceutical Excipients Product Portfolios and Specifications
Table 76. BASF SE Biopharmaceutical Excipients Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 77. BASF SE Main Business
Table 78. BASF SE Latest Developments
Table 79. ABITEC Corp Basic Information, Biopharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 80. ABITEC Corp Biopharmaceutical Excipients Product Portfolios and Specifications
Table 81. ABITEC Corp Biopharmaceutical Excipients Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 82. ABITEC Corp Main Business
Table 83. ABITEC Corp Latest Developments
Table 84. Colorcon, Inc Basic Information, Biopharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 85. Colorcon, Inc Biopharmaceutical Excipients Product Portfolios and Specifications
Table 86. Colorcon, Inc Biopharmaceutical Excipients Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. Colorcon, Inc Main Business
Table 88. Colorcon, Inc Latest Developments
Table 89. DFE Pharma Basic Information, Biopharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 90. DFE Pharma Biopharmaceutical Excipients Product Portfolios and Specifications
Table 91. DFE Pharma Biopharmaceutical Excipients Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 92. DFE Pharma Main Business
Table 93. DFE Pharma Latest Developments
Table 94. Meggle AG Basic Information, Biopharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 95. Meggle AG Biopharmaceutical Excipients Product Portfolios and Specifications
Table 96. Meggle AG Biopharmaceutical Excipients Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 97. Meggle AG Main Business
Table 98. Meggle AG Latest Developments
Table 99. Pharmonix Biological Basic Information, Biopharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 100. Pharmonix Biological Biopharmaceutical Excipients Product Portfolios and Specifications
Table 101. Pharmonix Biological Biopharmaceutical Excipients Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 102. Pharmonix Biological Main Business
Table 103. Pharmonix Biological Latest Developments
Table 104. Roquette Basic Information, Biopharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 105. Roquette Biopharmaceutical Excipients Product Portfolios and Specifications
Table 106. Roquette Biopharmaceutical Excipients Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 107. Roquette Main Business
Table 108. Roquette Latest Developments
Table 109. Sigachi Industries Basic Information, Biopharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 110. Sigachi Industries Biopharmaceutical Excipients Product Portfolios and Specifications
Table 111. Sigachi Industries Biopharmaceutical Excipients Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 112. Sigachi Industries Main Business
Table 113. Sigachi Industries Latest Developments
Table 114. Signet Chemical Corporation Basic Information, Biopharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 115. Signet Chemical Corporation Biopharmaceutical Excipients Product Portfolios and Specifications
Table 116. Signet Chemical Corporation Biopharmaceutical Excipients Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 117. Signet Chemical Corporation Main Business
Table 118. Signet Chemical Corporation Latest Developments
Table 119. Spectrum Chemical Manufacturing Corp Basic Information, Biopharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 120. Spectrum Chemical Manufacturing Corp Biopharmaceutical Excipients Product Portfolios and Specifications
Table 121. Spectrum Chemical Manufacturing Corp Biopharmaceutical Excipients Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. Spectrum Chemical Manufacturing Corp Main Business
Table 123. Spectrum Chemical Manufacturing Corp Latest Developments
Table 124. SPI Pharma Basic Information, Biopharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 125. SPI Pharma Biopharmaceutical Excipients Product Portfolios and Specifications
Table 126. SPI Pharma Biopharmaceutical Excipients Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. SPI Pharma Main Business
Table 128. SPI Pharma Latest Developments
Table 1. Biopharmaceutical Excipients Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Biopharmaceutical Excipients Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Solubilizers& Surfactants/Emulsifiers
Table 4. Major Players of Polyols
Table 5. Major Players of Carbohydrates
Table 6. Major Players of Other
Table 7. Global Biopharmaceutical Excipients Sales by Type (2020-2025) & (K MT)
Table 8. Global Biopharmaceutical Excipients Sales Market Share by Type (2020-2025)
Table 9. Global Biopharmaceutical Excipients Revenue by Type (2020-2025) & ($ million)
Table 10. Global Biopharmaceutical Excipients Revenue Market Share by Type (2020-2025)
Table 11. Global Biopharmaceutical Excipients Sale Price by Type (2020-2025) & (USD/MT)
Table 12. Global Biopharmaceutical Excipients Sale by Application (2020-2025) & (K MT)
Table 13. Global Biopharmaceutical Excipients Sale Market Share by Application (2020-2025)
Table 14. Global Biopharmaceutical Excipients Revenue by Application (2020-2025) & ($ million)
Table 15. Global Biopharmaceutical Excipients Revenue Market Share by Application (2020-2025)
Table 16. Global Biopharmaceutical Excipients Sale Price by Application (2020-2025) & (USD/MT)
Table 17. Global Biopharmaceutical Excipients Sales by Company (2020-2025) & (K MT)
Table 18. Global Biopharmaceutical Excipients Sales Market Share by Company (2020-2025)
Table 19. Global Biopharmaceutical Excipients Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Biopharmaceutical Excipients Revenue Market Share by Company (2020-2025)
Table 21. Global Biopharmaceutical Excipients Sale Price by Company (2020-2025) & (USD/MT)
Table 22. Key Manufacturers Biopharmaceutical Excipients Producing Area Distribution and Sales Area
Table 23. Players Biopharmaceutical Excipients Products Offered
Table 24. Biopharmaceutical Excipients Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Biopharmaceutical Excipients Sales by Geographic Region (2020-2025) & (K MT)
Table 28. Global Biopharmaceutical Excipients Sales Market Share Geographic Region (2020-2025)
Table 29. Global Biopharmaceutical Excipients Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Biopharmaceutical Excipients Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Biopharmaceutical Excipients Sales by Country/Region (2020-2025) & (K MT)
Table 32. Global Biopharmaceutical Excipients Sales Market Share by Country/Region (2020-2025)
Table 33. Global Biopharmaceutical Excipients Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Biopharmaceutical Excipients Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Biopharmaceutical Excipients Sales by Country (2020-2025) & (K MT)
Table 36. Americas Biopharmaceutical Excipients Sales Market Share by Country (2020-2025)
Table 37. Americas Biopharmaceutical Excipients Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Biopharmaceutical Excipients Sales by Type (2020-2025) & (K MT)
Table 39. Americas Biopharmaceutical Excipients Sales by Application (2020-2025) & (K MT)
Table 40. APAC Biopharmaceutical Excipients Sales by Region (2020-2025) & (K MT)
Table 41. APAC Biopharmaceutical Excipients Sales Market Share by Region (2020-2025)
Table 42. APAC Biopharmaceutical Excipients Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Biopharmaceutical Excipients Sales by Type (2020-2025) & (K MT)
Table 44. APAC Biopharmaceutical Excipients Sales by Application (2020-2025) & (K MT)
Table 45. Europe Biopharmaceutical Excipients Sales by Country (2020-2025) & (K MT)
Table 46. Europe Biopharmaceutical Excipients Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Biopharmaceutical Excipients Sales by Type (2020-2025) & (K MT)
Table 48. Europe Biopharmaceutical Excipients Sales by Application (2020-2025) & (K MT)
Table 49. Middle East & Africa Biopharmaceutical Excipients Sales by Country (2020-2025) & (K MT)
Table 50. Middle East & Africa Biopharmaceutical Excipients Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Biopharmaceutical Excipients Sales by Type (2020-2025) & (K MT)
Table 52. Middle East & Africa Biopharmaceutical Excipients Sales by Application (2020-2025) & (K MT)
Table 53. Key Market Drivers & Growth Opportunities of Biopharmaceutical Excipients
Table 54. Key Market Challenges & Risks of Biopharmaceutical Excipients
Table 55. Key Industry Trends of Biopharmaceutical Excipients
Table 56. Biopharmaceutical Excipients Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Biopharmaceutical Excipients Distributors List
Table 59. Biopharmaceutical Excipients Customer List
Table 60. Global Biopharmaceutical Excipients Sales Forecast by Region (2026-2031) & (K MT)
Table 61. Global Biopharmaceutical Excipients Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Biopharmaceutical Excipients Sales Forecast by Country (2026-2031) & (K MT)
Table 63. Americas Biopharmaceutical Excipients Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Biopharmaceutical Excipients Sales Forecast by Region (2026-2031) & (K MT)
Table 65. APAC Biopharmaceutical Excipients Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Biopharmaceutical Excipients Sales Forecast by Country (2026-2031) & (K MT)
Table 67. Europe Biopharmaceutical Excipients Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Biopharmaceutical Excipients Sales Forecast by Country (2026-2031) & (K MT)
Table 69. Middle East & Africa Biopharmaceutical Excipients Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Biopharmaceutical Excipients Sales Forecast by Type (2026-2031) & (K MT)
Table 71. Global Biopharmaceutical Excipients Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Biopharmaceutical Excipients Sales Forecast by Application (2026-2031) & (K MT)
Table 73. Global Biopharmaceutical Excipients Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. BASF SE Basic Information, Biopharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 75. BASF SE Biopharmaceutical Excipients Product Portfolios and Specifications
Table 76. BASF SE Biopharmaceutical Excipients Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 77. BASF SE Main Business
Table 78. BASF SE Latest Developments
Table 79. ABITEC Corp Basic Information, Biopharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 80. ABITEC Corp Biopharmaceutical Excipients Product Portfolios and Specifications
Table 81. ABITEC Corp Biopharmaceutical Excipients Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 82. ABITEC Corp Main Business
Table 83. ABITEC Corp Latest Developments
Table 84. Colorcon, Inc Basic Information, Biopharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 85. Colorcon, Inc Biopharmaceutical Excipients Product Portfolios and Specifications
Table 86. Colorcon, Inc Biopharmaceutical Excipients Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. Colorcon, Inc Main Business
Table 88. Colorcon, Inc Latest Developments
Table 89. DFE Pharma Basic Information, Biopharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 90. DFE Pharma Biopharmaceutical Excipients Product Portfolios and Specifications
Table 91. DFE Pharma Biopharmaceutical Excipients Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 92. DFE Pharma Main Business
Table 93. DFE Pharma Latest Developments
Table 94. Meggle AG Basic Information, Biopharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 95. Meggle AG Biopharmaceutical Excipients Product Portfolios and Specifications
Table 96. Meggle AG Biopharmaceutical Excipients Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 97. Meggle AG Main Business
Table 98. Meggle AG Latest Developments
Table 99. Pharmonix Biological Basic Information, Biopharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 100. Pharmonix Biological Biopharmaceutical Excipients Product Portfolios and Specifications
Table 101. Pharmonix Biological Biopharmaceutical Excipients Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 102. Pharmonix Biological Main Business
Table 103. Pharmonix Biological Latest Developments
Table 104. Roquette Basic Information, Biopharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 105. Roquette Biopharmaceutical Excipients Product Portfolios and Specifications
Table 106. Roquette Biopharmaceutical Excipients Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 107. Roquette Main Business
Table 108. Roquette Latest Developments
Table 109. Sigachi Industries Basic Information, Biopharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 110. Sigachi Industries Biopharmaceutical Excipients Product Portfolios and Specifications
Table 111. Sigachi Industries Biopharmaceutical Excipients Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 112. Sigachi Industries Main Business
Table 113. Sigachi Industries Latest Developments
Table 114. Signet Chemical Corporation Basic Information, Biopharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 115. Signet Chemical Corporation Biopharmaceutical Excipients Product Portfolios and Specifications
Table 116. Signet Chemical Corporation Biopharmaceutical Excipients Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 117. Signet Chemical Corporation Main Business
Table 118. Signet Chemical Corporation Latest Developments
Table 119. Spectrum Chemical Manufacturing Corp Basic Information, Biopharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 120. Spectrum Chemical Manufacturing Corp Biopharmaceutical Excipients Product Portfolios and Specifications
Table 121. Spectrum Chemical Manufacturing Corp Biopharmaceutical Excipients Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. Spectrum Chemical Manufacturing Corp Main Business
Table 123. Spectrum Chemical Manufacturing Corp Latest Developments
Table 124. SPI Pharma Basic Information, Biopharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 125. SPI Pharma Biopharmaceutical Excipients Product Portfolios and Specifications
Table 126. SPI Pharma Biopharmaceutical Excipients Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. SPI Pharma Main Business
Table 128. SPI Pharma Latest Developments
LIST OF FIGURES
Figure 1. Picture of Biopharmaceutical Excipients
Figure 2. Biopharmaceutical Excipients Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Biopharmaceutical Excipients Sales Growth Rate 2020-2031 (K MT)
Figure 7. Global Biopharmaceutical Excipients Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Biopharmaceutical Excipients Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Biopharmaceutical Excipients Sales Market Share by Country/Region (2024)
Figure 10. Biopharmaceutical Excipients Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Solubilizers& Surfactants/Emulsifiers
Figure 12. Product Picture of Polyols
Figure 13. Product Picture of Carbohydrates
Figure 14. Product Picture of Other
Figure 15. Global Biopharmaceutical Excipients Sales Market Share by Type in 2025
Figure 16. Global Biopharmaceutical Excipients Revenue Market Share by Type (2020-2025)
Figure 17. Biopharmaceutical Excipients Consumed in Biopharmaceutical Downstream
Figure 18. Global Biopharmaceutical Excipients Market: Biopharmaceutical Downstream (2020-2025) & (K MT)
Figure 19. Biopharmaceutical Excipients Consumed in Biopharmaceutical Upstream
Figure 20. Global Biopharmaceutical Excipients Market: Biopharmaceutical Upstream (2020-2025) & (K MT)
Figure 21. Global Biopharmaceutical Excipients Sale Market Share by Application (2024)
Figure 22. Global Biopharmaceutical Excipients Revenue Market Share by Application in 2025
Figure 23. Biopharmaceutical Excipients Sales by Company in 2025 (K MT)
Figure 24. Global Biopharmaceutical Excipients Sales Market Share by Company in 2025
Figure 25. Biopharmaceutical Excipients Revenue by Company in 2025 ($ millions)
Figure 26. Global Biopharmaceutical Excipients Revenue Market Share by Company in 2025
Figure 27. Global Biopharmaceutical Excipients Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Biopharmaceutical Excipients Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Biopharmaceutical Excipients Sales 2020-2025 (K MT)
Figure 30. Americas Biopharmaceutical Excipients Revenue 2020-2025 ($ millions)
Figure 31. APAC Biopharmaceutical Excipients Sales 2020-2025 (K MT)
Figure 32. APAC Biopharmaceutical Excipients Revenue 2020-2025 ($ millions)
Figure 33. Europe Biopharmaceutical Excipients Sales 2020-2025 (K MT)
Figure 34. Europe Biopharmaceutical Excipients Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Biopharmaceutical Excipients Sales 2020-2025 (K MT)
Figure 36. Middle East & Africa Biopharmaceutical Excipients Revenue 2020-2025 ($ millions)
Figure 37. Americas Biopharmaceutical Excipients Sales Market Share by Country in 2025
Figure 38. Americas Biopharmaceutical Excipients Revenue Market Share by Country (2020-2025)
Figure 39. Americas Biopharmaceutical Excipients Sales Market Share by Type (2020-2025)
Figure 40. Americas Biopharmaceutical Excipients Sales Market Share by Application (2020-2025)
Figure 41. United States Biopharmaceutical Excipients Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Biopharmaceutical Excipients Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Biopharmaceutical Excipients Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Biopharmaceutical Excipients Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Biopharmaceutical Excipients Sales Market Share by Region in 2025
Figure 46. APAC Biopharmaceutical Excipients Revenue Market Share by Region (2020-2025)
Figure 47. APAC Biopharmaceutical Excipients Sales Market Share by Type (2020-2025)
Figure 48. APAC Biopharmaceutical Excipients Sales Market Share by Application (2020-2025)
Figure 49. China Biopharmaceutical Excipients Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Biopharmaceutical Excipients Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Biopharmaceutical Excipients Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Biopharmaceutical Excipients Revenue Growth 2020-2025 ($ millions)
Figure 53. India Biopharmaceutical Excipients Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Biopharmaceutical Excipients Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Biopharmaceutical Excipients Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Biopharmaceutical Excipients Sales Market Share by Country in 2025
Figure 57. Europe Biopharmaceutical Excipients Revenue Market Share by Country (2020-2025)
Figure 58. Europe Biopharmaceutical Excipients Sales Market Share by Type (2020-2025)
Figure 59. Europe Biopharmaceutical Excipients Sales Market Share by Application (2020-2025)
Figure 60. Germany Biopharmaceutical Excipients Revenue Growth 2020-2025 ($ millions)
Figure 61. France Biopharmaceutical Excipients Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Biopharmaceutical Excipients Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Biopharmaceutical Excipients Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Biopharmaceutical Excipients Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Biopharmaceutical Excipients Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Biopharmaceutical Excipients Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Biopharmaceutical Excipients Sales Market Share by Application (2020-2025)
Figure 68. Egypt Biopharmaceutical Excipients Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Biopharmaceutical Excipients Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Biopharmaceutical Excipients Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Biopharmaceutical Excipients Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Biopharmaceutical Excipients Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Biopharmaceutical Excipients in 2025
Figure 74. Manufacturing Process Analysis of Biopharmaceutical Excipients
Figure 75. Industry Chain Structure of Biopharmaceutical Excipients
Figure 76. Channels of Distribution
Figure 77. Global Biopharmaceutical Excipients Sales Market Forecast by Region (2026-2031)
Figure 78. Global Biopharmaceutical Excipients Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Biopharmaceutical Excipients Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Biopharmaceutical Excipients Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Biopharmaceutical Excipients Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Biopharmaceutical Excipients Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Biopharmaceutical Excipients
Figure 2. Biopharmaceutical Excipients Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Biopharmaceutical Excipients Sales Growth Rate 2020-2031 (K MT)
Figure 7. Global Biopharmaceutical Excipients Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Biopharmaceutical Excipients Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Biopharmaceutical Excipients Sales Market Share by Country/Region (2024)
Figure 10. Biopharmaceutical Excipients Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Solubilizers& Surfactants/Emulsifiers
Figure 12. Product Picture of Polyols
Figure 13. Product Picture of Carbohydrates
Figure 14. Product Picture of Other
Figure 15. Global Biopharmaceutical Excipients Sales Market Share by Type in 2025
Figure 16. Global Biopharmaceutical Excipients Revenue Market Share by Type (2020-2025)
Figure 17. Biopharmaceutical Excipients Consumed in Biopharmaceutical Downstream
Figure 18. Global Biopharmaceutical Excipients Market: Biopharmaceutical Downstream (2020-2025) & (K MT)
Figure 19. Biopharmaceutical Excipients Consumed in Biopharmaceutical Upstream
Figure 20. Global Biopharmaceutical Excipients Market: Biopharmaceutical Upstream (2020-2025) & (K MT)
Figure 21. Global Biopharmaceutical Excipients Sale Market Share by Application (2024)
Figure 22. Global Biopharmaceutical Excipients Revenue Market Share by Application in 2025
Figure 23. Biopharmaceutical Excipients Sales by Company in 2025 (K MT)
Figure 24. Global Biopharmaceutical Excipients Sales Market Share by Company in 2025
Figure 25. Biopharmaceutical Excipients Revenue by Company in 2025 ($ millions)
Figure 26. Global Biopharmaceutical Excipients Revenue Market Share by Company in 2025
Figure 27. Global Biopharmaceutical Excipients Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Biopharmaceutical Excipients Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Biopharmaceutical Excipients Sales 2020-2025 (K MT)
Figure 30. Americas Biopharmaceutical Excipients Revenue 2020-2025 ($ millions)
Figure 31. APAC Biopharmaceutical Excipients Sales 2020-2025 (K MT)
Figure 32. APAC Biopharmaceutical Excipients Revenue 2020-2025 ($ millions)
Figure 33. Europe Biopharmaceutical Excipients Sales 2020-2025 (K MT)
Figure 34. Europe Biopharmaceutical Excipients Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Biopharmaceutical Excipients Sales 2020-2025 (K MT)
Figure 36. Middle East & Africa Biopharmaceutical Excipients Revenue 2020-2025 ($ millions)
Figure 37. Americas Biopharmaceutical Excipients Sales Market Share by Country in 2025
Figure 38. Americas Biopharmaceutical Excipients Revenue Market Share by Country (2020-2025)
Figure 39. Americas Biopharmaceutical Excipients Sales Market Share by Type (2020-2025)
Figure 40. Americas Biopharmaceutical Excipients Sales Market Share by Application (2020-2025)
Figure 41. United States Biopharmaceutical Excipients Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Biopharmaceutical Excipients Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Biopharmaceutical Excipients Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Biopharmaceutical Excipients Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Biopharmaceutical Excipients Sales Market Share by Region in 2025
Figure 46. APAC Biopharmaceutical Excipients Revenue Market Share by Region (2020-2025)
Figure 47. APAC Biopharmaceutical Excipients Sales Market Share by Type (2020-2025)
Figure 48. APAC Biopharmaceutical Excipients Sales Market Share by Application (2020-2025)
Figure 49. China Biopharmaceutical Excipients Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Biopharmaceutical Excipients Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Biopharmaceutical Excipients Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Biopharmaceutical Excipients Revenue Growth 2020-2025 ($ millions)
Figure 53. India Biopharmaceutical Excipients Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Biopharmaceutical Excipients Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Biopharmaceutical Excipients Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Biopharmaceutical Excipients Sales Market Share by Country in 2025
Figure 57. Europe Biopharmaceutical Excipients Revenue Market Share by Country (2020-2025)
Figure 58. Europe Biopharmaceutical Excipients Sales Market Share by Type (2020-2025)
Figure 59. Europe Biopharmaceutical Excipients Sales Market Share by Application (2020-2025)
Figure 60. Germany Biopharmaceutical Excipients Revenue Growth 2020-2025 ($ millions)
Figure 61. France Biopharmaceutical Excipients Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Biopharmaceutical Excipients Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Biopharmaceutical Excipients Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Biopharmaceutical Excipients Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Biopharmaceutical Excipients Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Biopharmaceutical Excipients Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Biopharmaceutical Excipients Sales Market Share by Application (2020-2025)
Figure 68. Egypt Biopharmaceutical Excipients Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Biopharmaceutical Excipients Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Biopharmaceutical Excipients Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Biopharmaceutical Excipients Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Biopharmaceutical Excipients Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Biopharmaceutical Excipients in 2025
Figure 74. Manufacturing Process Analysis of Biopharmaceutical Excipients
Figure 75. Industry Chain Structure of Biopharmaceutical Excipients
Figure 76. Channels of Distribution
Figure 77. Global Biopharmaceutical Excipients Sales Market Forecast by Region (2026-2031)
Figure 78. Global Biopharmaceutical Excipients Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Biopharmaceutical Excipients Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Biopharmaceutical Excipients Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Biopharmaceutical Excipients Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Biopharmaceutical Excipients Revenue Market Share Forecast by Application (2026-2031)
More Publications
Global Single-Use Technology for Biopharmaceuticals Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
March 2024
106 pages
